|
|
2025PA-A001 |
CJ168, an active component of Antrodia cinnamomea, attenuates non-alcoholic steatohepatitis progression |
陳信穎 |
|
|
|
2025PA-A002 |
以超高效能液相層析-高解析四極桿串聯傅立葉轉換電場軌道質譜儀建立心血管藥品中主成分衍生亞硝胺不純物之多重分析平臺 |
葉姿妘 |
|
|
|
2025PA-A003 |
Formulation and Optimization of Gefitinib-Loaded Niosomes for Inhalation Therapy |
黃聖閔 |
|
|
|
2025PA-A004 |
Polycation surface-modified Metal Organic Framework (MOF) loaded with Platinum (IV) Prodrug and Methotrexate for Synergistic Anticancer Therapy |
何志平 |
|
|
|
2025PA-A005 |
Targeted Nanoparticles for Precision Drug Delivery in Pancreatic Cancer |
孫唯珈 |
|
|
|
2025PA-A006 |
Nanoparticles Inducing Immunogenic Cell Death to Overcome Tumor Immune Evasion |
黃浩綸 |
|
|
|
2025PA-A007 |
Population Pharmacokinetic Modeling of Mosapride as a CYP3A Probe for Rivaroxaban Exposure Estimation
|
杜建龍 |
|
|
|
2025PA-A008 |
Development and Optimization of Sorafenib-Loaded Liposomal Dry Powder Formulation for Pulmonary Delivery |
陳思彤 |
|
|
|
2025PA-A009 |
Preparation and characterization of novel pH sensitive microgel system based on natural polymers glutamic acid-co-alginate for enhanced oral bioavailability of lipophilic drug |
Hamid Ullah |
|
|
|
2025PA-A010 |
mRNA疫苗核酸含量與包覆率方法開發 |
林伯霖 |
|
|
|
2025PA-B001 |
Health-Related Quality of Life in COPD Patients: Correlation between EQ-5D-5L and SGRQ |
李銘文 |
|
|
|
2025PA-B002 |
Opioid and Benzodiazepine Use Patterns and Risk of Acute Care Utilization |
蘇芳玉 |
|
|
|
2025PA-B003 |
Economic Evaluation of Atogepant versus Placebo for the Preventive Treatment of Episodic Migraine in Taiwan |
方靖媛 |
|
|
|
2025PA-B004 |
Comparison of Bispecific T-Cell Engager Antibodies and CAR-T Therapies for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis |
張淳瑄 |
|
|
|
2025PA-B005 |
Characterization of T-Cell Receptor Repertoire for Dengue Severity |
馮聖翔 |
|
|
|
2025PA-B006 |
Impact of a Medication Question Prompt List on Statin Knowledge Among Community Pharmacy Patients |
陳崇鈺 |
|
|
|
2025PA-B007 |
Effects of 5-alpha reductase inhibitors on the incidence and prognosis of bladder cancer： A systematic review and meta-analysis |
李柏志 |
|
|
|
2025PA-B008 |
Assessing Type 2 Diabetes Hazard in Chronic Hepatitis C Patients Under Direct-Acting Antiviral Treatment |
鄧翰良 |
|
|
|
2025PA-B009 |
T Cell Receptor Repertoire modulated by mRNA-1273 within ChAdOx1-S Inoculated Population |
周聖博 |
|
|
|
2025PA-B010 |
Innovative Approaches to Heart Failure Management Using Structured Medical Records and Data Visualization Tools |
吳承誌 |
|
|
|
2025PA-B011 |
Vitamin D₃ Status in Adults Residing in Central Coastal Taiwan: A Regional Analysis of Demographic and Clinical Correlates |
林金堆 |
|
|
|
2025PA-B012 |
基於RAG藥物諮詢對話系統設計與實作 |
徐偉智 |
|
|
|
2025PA-B013 |
Imatinib引起之dress syndrome |
侯如容 |
|
|
|
2025PA-B014 |
Integrating Multi-Omic Data, Polygenic Scores, and Real-World Clinical Evidence to Prioritize Drug Repurposing Candidates for Kidney Disease |
林旻柔 |
|
|
|
2025PA-B015 |
Intermediate Clinical Outcomes of ML-Based CDSS in Staphylococcus aureus and Klebsiella pneumoniae Infections: Analysis of 1,393 Patients |
何虂菁 |
|
|
|
2025PA-B016 |
從資料到對話: 醫藥諮詢對話系統之資料前處理策略與流程 |
吳欣憓 |
|
|
|
2025PA-B018 |
運用品管手法優化藥品盤點流程：藥師執業服務效能與病人安全的提升 |
黃郁文 |
|
|
|
2025PA-B019 |
The Assessment of the Medication Therapy Problems related to Fall in Older Adults Receiving Home Care by Hospital Clinical Pharmacists |
陳秋如 |
|
|
|
2025PA-C002 |
臺灣醫藥法規科學教育體系之推動與演進 |
謝瑀心 |
|
|
|
2025PA-C003 |
Factors Associated with High or Low Medication Literacy: Regional Matter in Comparing Northern vs. Non-Northern in Taiwan |
Dalin Yeang |
|
|
|
2025PA-C004 |
偏鄉藥品配送面臨GDP政策挑戰之實證研究：以花蓮與台東地區為例 |
鄭光成 |
|
|
|
2025PA-C005 |
以藥事法第103條之立法經緯論衛福部318解釋令之爭 |
施妤青 |
|
|
|
2025PE-A001 |
Trend Analysis of Gold Nanoparticles for Lung Cancer |
林容萱 |
|
|
|
2025PE-A002 |
醫療器材商業模式之探討-以F產品為例 |
曾鈺雯 |
|
|
|
2025PE-A006 |
新穎ROCK/PKC複合標靶藥物DR-001具治療糖尿病黃斑部水腫的應用潛力 |
王文瑜 |
|
|
|
2025PE-A007 |
Bioactive Extracts and Componds from Taraxacum mongolicum: Pharmacological and Molecular Docking Analysis |
黃冠穎 |
|
|
|
2025PE-A008 |
mRNA疫苗LNP之分析方法開發 |
詹鈞凱 |
|
|
|
2025PE-A009 |
Development of swellable microgels Formulations based on K-carrageenan and collagen for wound healing applications |
陳羿甫 |
|
|
|
2025PE-A010 |
Bioequivalence Between Two Orally Disintegrating Tablets of Olanzapine Manufactured by Different Processes |
沈文宗 |
|
|
|
2025PE-A011 |
Chemical Constituents from the Seeds of Benincasa hispida and iNOS Inhibitory Effects of Benincaside A
|
郭賓崇 |
|
|
|
2025PE-A012 |
An Integrated Network Pharmacology and Experimental Approach: Apoptosis-Regulating Potential of Fruit Spikes of Prunella vulgaris Against Non-Small Cell Lung Cancer |
李欣珉 |
|
|
|
2025PE-A013 |
Molecular Mechanisms of Mitochondrial Apoptosis Induced by Coptis chinensis in U87 Glioblastoma Cells |
蔡逸宏 |
|
|
|
2025PE-A014 |
A Nano-Drug Delivery System Based on Solvent-Mediated Browning Reaction of Tryptophan and Basic Amino Acids |
Shao-Kai Chin |
|
|
|
2025PE-A015 |
Main Bioactive Components and Their Biological Activities from the Root of Scutellaria baicalensis |
胡文馨 |
|
|
|
2025PE-A016 |
Ethnopharmacological study of herbal remedies used for the management of allergic rhinitis in Kinmen |
黃世勳 |
|
|
|
2025PE-A017 |
Formulation development and evaluation of orally disintegrating tablets of nicardipine hydrochloride |
羅永光 |
|
|
|
2025PE-A018 |
Beyond Underestimation: Reimagining IVIVE Through Microenvironment and Volume Correction for Hepatic Clearance |
鄭信忠 |
|
|
|
2025PE-A019 |
壯陽類西藥類緣物之檢測方法開發 |
王慧瑋 |
|
|
|
2025PE-A020 |
黃精炮製前後藥效評估 |
劉崇喜 |
|
|
|
2025PE-A021 |
The regulatory role of mitochonic acid 5 on platelet mitochondrial functions in sepsis |
周梅芳 |
|
|
|
2025PE-A022 |
Protective effects and mechanisms of triterpenoids and flavonoids isolated from Euphorbia formosana on lipopolysaccharide-induced inflammation in macrophages |
劉淑芬 |
|
|
|
2025PE-A023 |
Prodelphinidin B-2 3, 3’-di-O-gallate and Acyclovir act subsynergically on Inhibiting Herpes Simplex Virus type-2 Infection |
曾華友 |
|
|
|
2025PE-A024 |
Translational studies of paeonol on intracerebral hemorrhage models (in vitro and in vivo) |
黃卉如 |
|
|
|
2025PE-A025 |
某地區醫院ADC執行現況分析 |
王佑瑄 |
|
|
|
2025PE-A026 |
減肥藥新趨勢：淺談類大麻藥物 |
王毓輿 |
|
|
|
2025PE-B001 |
台灣常用中藥材進口統計（2019-2024年）與相關市場因素之綜合分析 |
羅志祥 |
|
|
|
2025PE-B002 |
Montelukast使用在Capsular Contracture之案例討論 |
黃郁文 |
|
|
|
2025PE-B003 |
口服A酸治療尋常性痤瘡的安全性 |
陳乙慈 |
|
|
|
2025PE-B004 |
藥師提供弱勢居家藥事服務後個案遵循醫囑領藥與使用藥物量表分數相關因素探討: 前導研究 |
李沛妤 |
|
|
|
2025PE-B005 |
冠狀動脈斑塊切割氣球導管與旋磨切除系統對塗藥氣球臨床採用之影響 |
劉桂梅 |
|
|
|
2025PE-B006 |
單次口服Ivermectin治療毛囊蟎眼瞼炎的療效：回溯性分析 |
林喬瑀 |
|
|
|
2025PE-B007 |
社區藥局藥事照護對高血壓病人用藥配合度之探討 |
褚婉齡 |
|
|
|
2025PE-B008 |
非處方藥通路上架決策影響因素之探討 |
盧偉娟 |
|
|
|
2025PE-B009 |
超高齡社會下社區藥局非處方藥經營模式之探討 |
楊聰義 |
|
|
|
2025PE-B010 |
基於生物資訊方法之rDNA 序列自動化分析與菌種鑑定系統開發 |
陳筱蕙 |
|
|
|
2025PE-B011 |
基於AI邊緣運算技術之藥品辨識設備 - 於花蓮某區域教學醫院之應用 |
林翰煒 |
|
|
|
2025PE-B012 |
中藥查詢系統圖像化之藥事資訊數位轉型：北部某醫學中心之建置與滿意度評估 |
廖培伶 |
|
|
|
2025PE-B013 |
偏鄉高齡長者多重之居家用藥整合服務探討——以臺南市大內區為例 |
蔡宗翰 |
|
|
|
2025PE-B014 |
從認知到行為：社區藥師衛教介入對臺中市成年居民鎮靜安眠藥安全使用的成效分析 |
許永慶 |
|
|
|
2025PE-B015 |
Therapeutic drug monitoring of tacrolimus in a renal transplant patient with CNS infection of Scedosporium boydii treated with voriconazole |
何睿凱 |
|
|
|
2025PE-B016 |
優化臨床試驗個別化禁用藥物管控系統 |
楊璦瑜 |
|
|
|
2025PE-B017 |
Ceftriaxone-Induced Immune Thrombocytopenia |
黃雲慧 |
|
|
|
2025PE-B018 |
PPIs related Stevens-Johnson syndrome |
施靜妤 |
|
|
|
2025PE-B019 |
Nationwide Analysis of Migraine Epidemiology, Comorbidities, and Medication Use in Taiwan |
方志文 |
|
|
|
2025PE-B020 |
Cinnarizine 誘發之史蒂芬強森症候群併毒性表皮壞死溶解症：案例報告暨文獻回顧 |
高汶琪 |
|
|
|
2025PE-B021 |
疑似Carboplatin引起之過敏性休克：案例報告 |
林昱男 |
|
|
|
2025PE-B022 |
Enhancing Heart Failure Management Through Multidisciplinary Pharmaceutical Care: Experience From a Regional Teaching Hospital in Southern Taiwan |
黃學揚 |
|
|
|
2025PE-B023 |
Evaluation of Lenalidomide Utilization in Patients with Multiple Myeloma at a Medical Center in Northern Taiwan |
忻彥君 |
|
|
|
2025PE-B024 |
A pilot study to investigate the association between serum concentration of osimertinib and clinical outcomes in non-small cell lung cancer patients |
何暐 |
|
|
|
2025PE-B025 |
PD-1抑制劑治療多種癌症的療效與安全性評估 |
鄭涵予 |
|
|
|
2025PE-B026 |
從文字到影音：AI 助力下的藥品衛教轉型策略 |
楊佩蓁 |
|
|
|
2025PE-B027 |
急診與夜間班次醫療環境中的用藥安全：個案分析 |
朱御鳳 |
|
|
|
2025PE-B028 |
Tolvaptan藥物使用評估 |
張耀元 |
|
|
|
2025PE-B029 |
化療調配成品傳送無紙化閉環作業 |
孫國祐 |
|
|
|
2025PE-B030 |
藥師介入急性心肌梗塞病人用藥遵從性照護成效分析 |
簡妙格 |
|
|
|
2025PE-B031 |
某醫學中心113至114年度Baloxavir與Oseltamivir之使用分析 |
葉哲瑄 |
|
|
|
2025PE-B032 |
Pharmacist-Led Interventions: Ticagrelor Prescribing Decisions and Medication Safety
藥師主導藥事介入：Ticagrelor 處方決策與用藥安全 |
邱士軒 |
|
|
|
2025PE-B033 |
藥師介入吸入劑教學對住院病人操作正確性之影響 |
潘虹方 |
|
|
|
2025PE-B034 |
Intrathecal administration of liposomal amphotericin B for the treatment of refractory cryptococcal meningitis in an HIV-infected patient: A case report |
李尉綺 |
|
|
|
2025PE-B035 |
探討中藥於乳癌輔助治療 |
王仕雯 |
|
|
|
2025PE-B036 |
Thiamine及積極的靜脈營養治療在雙側腹股溝疝氣術後腹膜炎及腸阻塞的幫助 |
張哲嘉 |
|
|
|
2025PE-B037 |
疑似Hydralazine誘發之聲帶麻痺 |
邱偌純 |
|
|
|
2025PE-B038 |
某地區醫院Warfarin藥物使用評估 |
林宜慧 |
|
|
|
2025PE-B039 |
Cefoxitin Sodium 在 Mycobacterium abscessus Complex 感染治療之應用：病例與文獻整合分析 |
蔡筱筑 |
|
|
|
2025PE-B040 |
某區域醫院門急診疑義處方統計分析及應效益 |
勞樂曦 |
|
|
|
2025PE-B041 |
某區域教學醫院藥物諮詢台藥師服務類型之型態分析 |
洪于婷 |
|
|
|
2025PE-B042 |
某地區醫院113年藥物諮詢服務類型分析 |
蕭芳如 |
|
|
|
2025PE-B043 |
長期使用Desmopressin造成低血鈉之案例報告 |
劉冠翎 |
|
|
|
2025PE-B044 |
某醫學中心Digoxin中毒案例報告 |
林婷暄 |
|
|
|
2025PE-B045 |
南部某區域醫院首次執行居家靜脈營養照護事前準備案例報告 |
蘇士銘 |
|
|
|
2025PE-B046 |
阿米巴性痢疾治療藥品Paromomycin之臨床使用評估與探討 |
王奇新 |
|
|
|
2025PE-B047 |
醫院中藥重金屬含量監測與安全性評估 |
王明傑 |
|
|
|
2025PE-B048 |
建構偏鄉高齡者「居家用藥整合藥事服務系統」以提升用藥安全—以臺南市大內區為例 |
梁峰賓 |
|
|
|
2025PE-C001 |
運用資訊系統及通訊平台提升藥庫藥品管理效率及病人用藥安全 |
李琇琳 |
|
|
|
2025PE-C002 |
第一階藥師國考準備行為與學習策略之探討：以南部某科大藥學生視角調查為例
|
柯柏全 |
|
|
|
2025PE-C003 |
以112年憲判字第17號論藥物廣告之限制 |
葉佳勳 |
|
|
|
2025PE-C004 |
藥學生於中部某醫學中心進行中藥160小時實習之學習成效與滿意度分析 |
楊佳蒨 |
|
|
|
2025PE-C005 |
Stakeholders' Attitudes toward Biosimilar Interchangeability Policy in Taiwan amid Global Regulatory Convergence |
李柏宏 |
|
|
|
2025PE-C006 |
優化連貫性評估教學設計以提升實習成效之初步經驗 |
許哲瑋 |
|
|
|
2025PE-C007 |
抗生素麻將教學對臨床抗生素判斷能力之教學成效分析 |
羅旭敏 |
|
|
|
2025PE-C008 |
某區域醫院藥劑部發展國際交流經驗分享 |
劉子瑋 |
|
|
|
2025PE-C009 |
社區藥局實習指導藥師培訓課程的數位轉型與混合式學習實踐 |
王四切 |
|
|
|
2025PE-C010 |
關懷據點老人醫藥常識認知及選擇意向之探討 |
盧依婷 |
|
|
|
2025PE-C011 |
結合擴增實境情境案例與多元教學於藥理學以提升學生之學習成效 |
陳秋蘭 |
|
|
|
2025PE-C012 |
某區域教學醫院對得不以製劑調製藥品之調製與管理經驗分享 |
孫屏翰 |
|
|
|
2025PE-C013 |
護理師在工作壓力下使用安眠藥現況影響因素之探討 |
蔡瓊君 |
|
|
|
2025PE-C014 |
台中市某藥品代理經銷商的營運策略與客戶整體滿意度之相關性研究
|
胡育瑋 |
|
|
|
2025PE-C015 |
南部某醫學中心年度提報常備藥品計劃常見疏失原因分析與改善 |
吳亭萱 |
|
|
|
2025PE-C016 |
南部某區域教學醫院就「醫療疏失後的藥師教育訓練改善經驗分享」 |
郭俶妏 |
|
|
|
2025PE-C017 |
Standardization of Storage Locations in a Long-Established Hospital Pharmacy |
王鴻展 |
|
|
|
2025PE-C018 |
論藥事法西藥之專利連結制度 |
林珈旨 |
|
|
|
2025PP-A001 |
SNP-6: Translating Multi-Mechanistic Efficacy from Preclinical Models to Phase 2a in MASH |
胡幼圃 |
|
|
|
2025PP-A002 |
A double-edged effect of hypoxia-preconditioned astrocyte-derived exosomes on hemin-induced neurotoxicity |
曾揚傑 |
|
|
|
2025PP-A003 |
To explore evidence-based mechanistic toxicology of Antrodia camphorata: synthesis, biopathways, and safety implications |
賴志韋 |
|